HealthLeaders Media April 24, 2024
John Commins

Spending on weight-loss drugs will continue to climb in 2024 and beyond as drug makers catch up with the huge global demand.

Eric Tichy, PharmD, MBA, division chair, supply chain management at Mayo Clinic, is lead author of a new study detailing how and where the U.S. spent $772 billion on drug in 2023, up 13.5% from 2022, and what’s in store for 2024.

In this HealthLeaders interview, Tichy explains how weight-loss drugs pushed double-digit increases in drug expenditures last year, even as drug price increases were relatively modest.

Tichy projects that spending on weight-loss drugs will continue to climb in 2024 and beyond as suppliers catch up with the huge global demand. That growth will continue as new...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health System / Hospital, Healthcare System, Interview / Q&A, Pharma, Pharma / Biotech, Pricing / Spending, Provider, Survey / Study, Trends
Why Walgreens Is Reportedly Considering a Private Equity Buyer
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
Why 2025 Could Be A Good Reimbursement Year For CVS And Walgreens
PBM reform dropped in Congress' funding package
2025 and Beyond: Key Trends to Watch in Pharmacy

Share This Article